Industry News (Joint Venture)

Cancer Therapy Clinical Research Collaboration Established

Published in Cancer Weekly, July 7th, 1997

Cytel Corp., San Diego, California, and the Immunotherapy Division of Baxter Healthcare Corp.'s Biotech Group, Irvine, California, announced that they have entered into a clinical research collaboration to develop an ex vivo cancer therapy.

Under the collaboration, a Phase I/II pilot study is initiated to assess the safety and potential effectiveness of treating malignant melanoma patients with tumor-specific cytotoxic T cells (CTL) produced from patient T cells and activated with peptide epitopes outside the body.

Under the agreement, Cytel provides melanoma-specific, CTL-stimulatory epitope peptides. Baxter provides cell separation systems and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1997-07-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry